Desviat L R, Pérez B, Pérez-Cerdá C, Rodríguez-Pombo P, Clavero S, Ugarte M
Centro de Biología Molecular "Severo Ochoa" CSIC-UAM, Universidad Autónoma de Madrid, Cantoblanco, 28049 Madrid, Spain.
Mol Genet Metab. 2004 Sep-Oct;83(1-2):28-37. doi: 10.1016/j.ymgme.2004.08.001.
Mutations in the PCCA or PCCB genes, encoding both subunits of propionyl-CoA carboxylase, result in propionic acidemia, a life-threatening inborn error of metabolism with autosomal recessive inheritance. To date, 41 mutations in the PCCA gene and 54 in the PCCB gene have been reported, most of them single base substitutions causing amino acid replacements, and a variety of small insertions and deletions and splicing defects. A greater heterogeneity is observed in the PCCA gene, specially in Caucasians, with no prevalent mutations, while in the Japanese population three mutations account for more than half of the alleles studied. For the PCCB gene a limited number of mutations is responsible for the majority of the alleles characterized in both Caucasian and Oriental populations. These two populations show a different mutational spectrum, only sharing some involving CpG dinucleotides probably as recurrent mutational events. Functional characterization of the mutant missense alleles has been accomplished using different prokaryotic and eukaryotic systems, and the structural consequences have been analyzed in the available crystal models. For the PCCA gene, the main molecular effect of the expressed mutations is related to protein instability, except two mutations in the active site predictably affecting ATP binding. In the PCCB gene the majority of the analyzed mutations are predicted to alter the active site conformation resulting in diminished activity. A few carboxy-terminal PCCB mutations affect the interaction between subunits and the assembly with PCCA to form a functional PCC oligomer. The amount of normal transcripts resulting from some PCCA and PCCB splicing mutations has also been analyzed. Overall, the data generated from the expression analysis reveal potential genotype-phenotype correlations for this clinically heterogeneous disorder.
编码丙酰辅酶A羧化酶两个亚基的PCCA或PCCB基因突变会导致丙酸血症,这是一种常染色体隐性遗传的、危及生命的先天性代谢缺陷病。迄今为止,已报道PCCA基因有41种突变,PCCB基因有54种突变,其中大多数是导致氨基酸替换的单碱基替换,还有各种小的插入、缺失和剪接缺陷。在PCCA基因中观察到更大的异质性,特别是在白种人中,没有普遍存在的突变,而在日本人群中,三种突变占所研究等位基因的一半以上。对于PCCB基因,少数突变导致白种人和东方人群中大多数已鉴定的等位基因出现病变。这两个人群显示出不同的突变谱,仅共享一些涉及CpG二核苷酸的突变,可能是作为反复发生的突变事件。已使用不同的原核和真核系统完成了突变错义等位基因的功能表征,并在可用的晶体模型中分析了其结构后果。对于PCCA基因,除了活性位点的两个突变可预测地影响ATP结合外,表达突变的主要分子效应与蛋白质不稳定性有关。在PCCB基因中,大多数分析的突变预计会改变活性位点构象,导致活性降低。一些PCCB基因羧基末端突变会影响亚基之间的相互作用以及与PCCA的组装,从而形成功能性PCC寡聚体。还分析了一些PCCA和PCCB剪接突变产生的正常转录本数量。总体而言,表达分析产生的数据揭示了这种临床异质性疾病潜在的基因型-表型相关性。